Evaluation of the Rationality of Drug Use in Patients with Dyspepsia at Anutapura Palu Hospital, Indonesia

Read full text
Authors: Arya Dibyo Adisaputra, Arda Arda, Andi Atirah Masyita, Muhammad Edy Rizal, Rudi Safarudin
Cited by: 0

Abstract

Dyspepsia is an abdominal discomfort that includes pain or discomfort in the upper region of the abdomen, accompanied by nausea, vomiting, bloating, a feeling of fullness, belching, and a sensation of heat in the chest. Dyspepsia ranked first in the top 10 outpatient diseases in 2021 at Anutapura Palu Hospital, with a total of 469 cases. The aim of this study was to determine the rationality of dyspepsia drug use at Anutapura Regional Hospital, Palu, based on the accuracy method, with the parameters of right indication, right drug, right dose, and right patient. The method used in this study is retrospective, utilizing patient medical record data from a specific period, namely August to December 2023. Then, rationality was assessed through accuracy parameters: the right indication, the right drug, the right dose, and the right patient. The rational use of drugs in inpatients with dyspepsia disease at Anutapura Palu Hospital in August-December 2023 with a total sample of 287 patients and 1,264 drug prescriptions based on four parameters—the right indication, the right drug, the right dose, and the right patient—obtained the results of the right indication 100%, the right drug 100%, the right patient 100%, and the right dose 99.53%, as well as inappropriate dose as many as 6 drugs (0.47%) of all prescribed drugs caused by overdose or underdose prescriptions. This indicates that overall, the use of drugs at Anutapura Palu Hospital is rational, with the majority of prescriptions meeting established standards.

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Pharmacy and Medical Practices Pharmaceutical studies and practices

Publication details

Journal / source
Mutiara Medika: Jurnal Kedokteran dan Kesehatan
Volume
26
Issue
1
Pages
29–37
Publication date
20 January 2026
Language
EN